BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15955946)

  • 1. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy.
    Lucioli S; Giusti B; Mercuri E; Vanegas OC; Lucarini L; Pietroni V; Urtizberea A; Ben Yaou R; de Visser M; van der Kooi AJ; Bönnemann C; Iannaccone ST; Merlini L; Bushby K; Muntoni F; Bertini E; Chu ML; Pepe G
    Neurology; 2005 Jun; 64(11):1931-7. PubMed ID: 15955946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
    Baker NL; Mörgelin M; Pace RA; Peat RA; Adams NE; Gardner RJ; Rowland LP; Miller G; De Jonghe P; Ceulemans B; Hannibal MC; Edwards M; Thompson EM; Jacobson R; Quinlivan RC; Aftimos S; Kornberg AJ; North KN; Bateman JF; Lamandé SR
    Ann Neurol; 2007 Oct; 62(4):390-405. PubMed ID: 17886299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
    Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
    Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.
    Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML
    Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures.
    Jöbsis GJ; Keizers H; Vreijling JP; de Visser M; Speer MC; Wolterman RA; Baas F; Bolhuis PA
    Nat Genet; 1996 Sep; 14(1):113-5. PubMed ID: 8782832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collagenopathy (Ullrich congenital muscular dystrophy, Bethlem myopathy)].
    Higuchi I
    Rinsho Shinkeigaku; 2005 Nov; 45(11):935-7. PubMed ID: 16447767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan.
    Okada M; Kawahara G; Noguchi S; Sugie K; Murayama K; Nonaka I; Hayashi YK; Nishino I
    Neurology; 2007 Sep; 69(10):1035-42. PubMed ID: 17785673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel COL6A1 splicing mutation in a family affected by mild Bethlem myopathy.
    Vanegas OC; Zhang RZ; Sabatelli P; Lattanzi G; Bencivenga P; Giusti B; Columbaro M; Chu ML; Merlini L; Pepe G
    Muscle Nerve; 2002 Apr; 25(4):513-9. PubMed ID: 11932968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal recessive inheritance of classic Bethlem myopathy.
    Foley AR; Hu Y; Zou Y; Columbus A; Shoffner J; Dunn DM; Weiss RB; Bönnemann CG
    Neuromuscul Disord; 2009 Dec; 19(12):813-7. PubMed ID: 19884007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.
    Lampe AK; Dunn DM; von Niederhausern AC; Hamil C; Aoyagi A; Laval SH; Marie SK; Chu ML; Swoboda K; Muntoni F; Bonnemann CG; Flanigan KM; Bushby KM; Weiss RB
    J Med Genet; 2005 Feb; 42(2):108-20. PubMed ID: 15689448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy.
    Pepe G; Giusti B; Bertini E; Brunelli T; Saitta B; Comeglio P; Bolognese A; Merlini L; Federici G; Abbate R; Chu ML
    Biochem Biophys Res Commun; 1999 May; 258(3):802-7. PubMed ID: 10329467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype.
    Scacheri PC; Gillanders EM; Subramony SH; Vedanarayanan V; Crowe CA; Thakore N; Bingler M; Hoffman EP
    Neurology; 2002 Feb; 58(4):593-602. PubMed ID: 11865138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy.
    Giusti B; Lucarini L; Pietroni V; Lucioli S; Bandinelli B; Sabatelli P; Squarzoni S; Petrini S; Gartioux C; Talim B; Roelens F; Merlini L; Topaloglu H; Bertini E; Guicheney P; Pepe G
    Ann Neurol; 2005 Sep; 58(3):400-10. PubMed ID: 16130093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem.
    Zou Y; Zhang RZ; Sabatelli P; Chu ML; Bönnemann CG
    J Neuropathol Exp Neurol; 2008 Feb; 67(2):144-54. PubMed ID: 18219255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families.
    Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR
    Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) gene.
    Kugler W; Pekrun A; Laspe P; Erdlenbruch B; Lakomek M
    Hum Mutat; 2001 Apr; 17(4):348. PubMed ID: 11295830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel de novo COL6A1 mutation emphasizes the role of intron 14 donor splice site defects as a cause of moderate-progressive form of ColVI myopathy - a case report and review of the genotype-phenotype correlation.
    Koppolu AA; Madej-Pilarczyk A; Rydzanicz M; Kosińska J; Gasperowicz P; Dorszewska J; Kozubski W; Steinborn B; Kochański AM; Płoski R
    Folia Neuropathol; 2017; 55(3):214-220. PubMed ID: 28984114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bethlem myopathy: long-term follow-up identifies COL6 mutations predicting severe clinical evolution.
    Deconinck N; Richard P; Allamand V; Behin A; Lafôret P; Ferreiro A; de Becdelievre A; Ledeuil C; Gartioux C; Nelson I; Carlier RY; Carlier P; Wahbi K; Romero N; Zabot MT; Bouhour F; Tiffreau V; Lacour A; Eymard B; Stojkovic T
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1337-46. PubMed ID: 25535305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci.
    Demir E; Ferreiro A; Sabatelli P; Allamand V; Makri S; Echenne B; Maraldi M; Merlini L; Topaloglu H; Guicheney P
    Neuropediatrics; 2004 Apr; 35(2):103-12. PubMed ID: 15127309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.